Methylation Test in Australia

What a methylation test is

Methylation testing measures the inputs and outputs of the one-carbon cycle — the set of reactions that transfer methyl groups around the body — rather than measuring 'methylation' as a single quantity.

Methylation is a chemical reaction, not an organ. A methyl group — one carbon and three hydrogens — is passed from a donor molecule to a recipient. The body performs this reaction billions of times a second to build neurotransmitters, recycle amino acids, package fats for transport, maintain the myelin sheath around nerves, and place the chemical marks that switch gene expression up and down.

There is no single blood test that reports 'your methylation'. What a laboratory can measure is whether the cycle has the raw materials it needs and whether its intermediates are accumulating. The headline metabolite is homocysteine. Homocysteine sits at the junction of the cycle: it is either re-methylated back into methionine, a reaction that consumes vitamin B12 and folate, or diverted down the transsulfuration pathway, which consumes vitamin B6. When either route is short of cofactors, homocysteine backs up and the blood level rises.

That makes homocysteine a functional read-out. A vitamin B12 level tells you how much is circulating; homocysteine tells you whether the reaction that depends on it is actually keeping up. Methylmalonic acid (MMA) does a similar job for a second, separate B12-dependent reaction, which is why an Australian laboratory will often add MMA when a B12 result is borderline.

Beware of the marketing gap here. Commercially promoted 'methylation profiles' sometimes bundle genetic variants, unvalidated urinary organic acids and personality-style 'over-methylator / under-methylator' classifications. Those classifications are not recognised in Australian pathology practice. The measurements described on this page are the ones a NATA-accredited laboratory can report against a validated reference interval.

Why methylation markers are measured

The panel is ordered to find a treatable nutritional deficiency, to explain an unexplained macrocytic anaemia or neurological symptom, and to quantify cardiovascular-risk-associated hyperhomocysteinaemia.

The clinically important point is that the deficiencies this panel detects are common, cheap to confirm and correctable — and that the neurological damage from prolonged B12 deficiency can become permanent. Finding it early matters more than any speculative interpretation of the cycle as a whole.

• Unexplained fatigue, brain fog or low mood where B12 or folate deficiency has not been excluded.
• Peripheral neuropathy, numbness, pins and needles or unsteady gait — B12 deficiency can damage nerves before it changes the blood count.
• A full blood count showing macrocytosis (raised mean cell volume) with or without anaemia.
• Long-term metformin, proton pump inhibitor or nitrous oxide exposure, all of which reduce B12 availability.
• Strict vegan or near-vegan eating without reliable B12 supplementation.
• Pre-conception and pregnancy planning, where folate status matters for neural tube development.
• A personal or family history of early cardiovascular or venous thromboembolic disease, where homocysteine is one of several markers a doctor may consider.

What a high homocysteine result can mean

Raised homocysteine most often reflects a shortage of vitamin B12, folate or B6, reduced kidney clearance, or an inherited enzyme defect — and it is a marker of risk, not a disease in itself.

The most common explanation for a mildly raised homocysteine in Australia is a nutritional one: insufficient B12, folate or B6 to sustain the two disposal routes. Reduced kidney function is the next most common, because the kidneys clear a substantial share of circulating homocysteine; a raised result alongside a raised creatinine usually reflects the kidney, not the vitamin.

Hypothyroidism, some medicines (including methotrexate, certain anticonvulsants and long-term metformin), heavy smoking and high alcohol intake all push the number up. Very high levels — well above the usual reference interval — raise the possibility of homocystinuria, an inherited metabolic disorder that is screened for at birth in Australia and which requires specialist metabolic care.

Epidemiological studies consistently associate elevated homocysteine with cardiovascular and cerebrovascular disease. Interventional trials that lowered homocysteine with B-vitamin supplementation have generally not produced the expected reduction in cardiovascular events, so the current mainstream view is that homocysteine is a useful marker of an underlying problem rather than a target to be treated in isolation. Whether your result warrants any action is a clinical judgement for your GP, made alongside your blood pressure, lipids, glucose, kidney function and family history.

What low B12 or folate results can mean

Low vitamin B12 or folate indicates a deficiency state that can cause macrocytic anaemia, glossitis and — in the case of B12 — progressive and potentially irreversible neurological injury.

Low B12 arises from inadequate intake, impaired absorption or increased loss. In Australia the classic absorption causes are pernicious anaemia (an autoimmune loss of intrinsic factor), atrophic gastritis, coeliac disease, Crohn's disease and previous gastric or ileal surgery. Medicines matter too: metformin and long-term acid suppression both reduce uptake, and repeated nitrous oxide exposure inactivates the vitamin directly.

Low folate is usually dietary, though malabsorption, pregnancy, chronic haemolysis and some medicines increase demand or reduce availability. Because Australian bread-making flour has been fortified with folic acid since 2009, frank dietary folate deficiency is now uncommon, and red cell folate is generally the more informative measure of longer-term status.

One trap is worth flagging: correcting folate while a B12 deficiency remains untreated can improve the blood count while allowing the neurological damage to continue. That is exactly why a laboratory reports the two together, and why a low result should be discussed with your GP rather than self-corrected from a supplement aisle.

Australian reference ranges

Australian laboratories report methylation-cycle markers in SI units — µmol/L for homocysteine and methylmalonic acid, pmol/L for vitamin B12 and nmol/L for folate.

Who should consider testing

Testing is most informative for people with symptoms or exposures that make B12 or folate deficiency plausible, rather than as an untargeted screen in healthy adults.

If none of those apply and you feel well, the yield is low and Choosing Wisely Australia's general advice against untargeted testing is worth taking seriously. A test only helps when the result will change something.

• Vegans, vegetarians and people who eat very little animal protein.
• Adults over 60, in whom absorption declines and atrophic gastritis is more common.
• Anyone on long-term metformin or a proton pump inhibitor.
• People with coeliac disease, Crohn's disease or previous bowel or gastric surgery.
• People with unexplained neuropathy, macrocytosis or unexplained fatigue.
• People planning a pregnancy who want to confirm folate and B12 status.

How testing works with FORM in Australia

You choose the panel, we issue an Australian pathology request form, you walk in for collection at an accredited centre, and you receive your results with reference ranges and a written plain-English explanation.

• No referral from your own GP is required. Privately requested pathology is arranged under a request from a registered medical practitioner working with our accredited lab partner.
• Collection is a walk-in at Laverty (Healius) pathology centres, which operate in every Australian state and territory.
• Homocysteine is sensitive to sample handling, so collection at an accredited centre with prompt processing matters.
• Results are reported in Australian SI units against the performing laboratory's own reference intervals.
• FORM is a diagnostic blood-testing service. We do not prescribe, supply or manage medicines — take your results to your GP or another registered Australian doctor.
• Australian ordering is currently pre-sale. Join the waitlist and we will let you know the moment it opens.